Compare ImmunityBio Inc. Common Stock (IBRX) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs SPDR Kensho Final Frontiers ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $9.98 (market cap $10.51B), while SPDR Kensho Final Frontiers ETF trades at $102.84 (market cap $170.14M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 61.8× SPDR Kensho Final Frontiers ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and SPDR Kensho Final Frontiers ETF for 8 Days on average.
| IBRX | ROKT | |
|---|---|---|
Market Cap | $10.51B | $170.14M |
Volume | 10,445,785 | 12,298 |
Sector | Health | Sector/Thematic |
52-Week High | $11.55 | $136.68 |
52-Week Low | $1.98 | $72.93 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $10.97B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →
